K. J. Beach

Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin.

N. Robert, C. Isaacs, B. Overmoyer, 1997, Journal of Clinical Oncology.

A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.

G. Rosen, J. Loewy, M. Gordon, 1996, Blood.